D-Day: Monday June 5 from 1:15-4:45pm CT.From Bloom Burton, "ESSA faces make-or-break data at ASCO (we expect results will be reported for the complete 2400 and partial 3600 mg cohorts). We continue to believe that strong mechanistic rationale exists for EPI-506 and rate EPIX stock BUY (Speculative Risk) with a target price of US$8.70 based on comparables and precedent transaction analysis."